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Abstract: Lower limb asymmetries have been observed in persons with multiple sclerosis (PwMS),
and have been associated with mobility impairment. An incremental cycling test was performed on a
cycle ergometer to determine peak power output (PPO) and peak oxygen consumption (VO2peak).
Then, participants cycled at 50%, 60%, and 70% of their PPO to assess the contribution of each lower
limb to power production. Two-way repeated measures ANOVA was used to detect group × intensity
differences in power production asymmetry. Eight PwMS and six healthy individuals (Non-MS)
completed the study. No statistically significant (p > 0.05) group× intensity interactions or main effects
were present when examining between-limb differences in power production. The current data do
not indicate a statistically significant difference in power production asymmetry between groups and
exercise intensities. Previous research has established a 10% difference between contralateral limbs as
a threshold for asymmetry. The average asymmetry in power production in PwMS exceeded the 10%
threshold at all measured outputs, suggesting the presence of asymmetry in power production.
Keywords: multiple sclerosis; asymmetry; exercise; lower extremity; walking
1. Introduction
Multiple sclerosis is a chronic neurological disease characterized by disruption in the propagation
of action potentials along the axons of neurons due to the demyelination of the myelin sheath [1].
The formation of scleroses, or plaques, in the white and gray matter of the brain and spinal
cord has been associated with negative alterations in the peripheral muscular tissue that includes:
reductions in enzyme oxidative capacity, impairment of the excitation–contraction coupling processes,
and atrophy [2–8]. Due to these alterations in muscle function and performance, persons with multiple
sclerosis (PwMS) can experience a lower exercise tolerance, an increase in the perceived difficulty to
perform activities of daily living, and a reduction in quality of life [9,10].
Previous observations suggest that PwMS may experience decrements in muscle function in an
asymmetrical pattern [3,11–13]. A greater decrement in muscle function is observed in a limb compared
to the contralateral limb, creating an imbalance between sides of the body. Lower limb asymmetry has
been observed in PwMS for: muscular strength, oxygen uptake, femoral neck bone mineral density,
and work performed and power output during unilateral incremental cycling [3,11–13]. Significant
associations have been observed between lower limb asymmetries and MS-related fatigue, although
other investigations have reported no associations [3,14]. Additionally, lower limb asymmetries have
been associated with walking impairment and postural instability [3,13]. Future investigations are
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required to further explore the potential negative effects of lower limb asymmetries on functional
capacity and MS-related symptoms.
Previous studies have assessed asymmetry by isolating the lower limbs and requiring each limb
to work independently of the other (i.e., unilateral cycling) [11–13]. Although this methodology has
provided valuable insight, it has not allowed for an assessment of how lower limb asymmetry may
influence natural bipedal movements and exercises, highlighting an area of research that needs to
be addressed. Additionally, previous research has predominately assessed asymmetry at maximal
intensities, with only one study assessing asymmetry in PwMS during unilateral cycling at low levels
of exercise intensity (20% of whole body peak workload) [11–13]. The physical manifestation of
asymmetry as being intensity dependent has yet to be evaluated in PwMS.
Extensive and consistent data is available to support the beneficial effects of exercise training on
muscular strength, aerobic capacity, and ambulatory performance in PwMS [15]. However, based
on previously reported associations, lower limb asymmetry may negatively impact PwMS’ ability to
safely participate in rehabilitation programs and exercise training. Lower limb asymmetry has not
previously been considered for exercise prescription in PwMS, potentially placing PwMS at increased
risk for falls during exercise. To better understand the impact of lower limb asymmetry on exercise
capacity in PwMS, assessing asymmetry during a natural bipedal movement in addition to assessing
the impact of exercise intensity on the manifestation of asymmetry is required. The integration of
dual power meters into cycle ergometers now allows for simultaneous limb assessment and the
quantification of each limb’s contribution to total power output during cycling while allowing for the
precise control of intensity in an exercise modality that is conducive for those who may be at risk for
falls. Therefore, the aims of the current study were to: (1) investigate whether PwMS exhibit greater
lower limb asymmetry in force application and power production contribution during double-leg
cycling compared to healthy controls, and (2) investigate how exercise intensity affects the physical
manifestation of lower limb asymmetry in PwMS. We hypothesized that (1) PwMS would exhibit
a greater lower limb asymmetry in force production and power production contribution during
cycling compared to healthy controls, and (2) that asymmetry in PwMS would be greatest at higher
exercise intensities. This study will provide new insight on the presentation and extent of lower limb
asymmetry in PwMS, which can inform the design and prescription of rehabilitation programs and
exercise training.
2. Materials and Methods
Research Design: The current study utilized a mixed factorial design and consisted of 4 laboratory
visits with a minimum of 48 h in between. All subjects gave their informed consent for inclusion
before they participated in the study. The study was conducted in accordance with the Declaration
of Helsinki, and the protocol was approved by the Institutional Review Board of the University of
Oklahoma (IRB number 8069). Visit 1 consisted of participants being familiarized with all equipment
and testing protocols prior to testing, and conducting a body composition assessment via a dual-energy
X-ray absorptiometry scan. During Visit 2, participants performed an incremental cycling test (ICT) to
task failure at a self-selected cadence to determine peak oxygen consumption (VO2peak) and peak
power output (PPO). Upon completion of the ICT, participants were allotted 20 minutes (min) of rest
before completing a verification protocol to validate the VO2peak and PPO determined from the ICT.
On Visit 3, participants completed a submaximal ICT that included stages at 50%, 60%, and 70% of
PPO. Walking capacity was assessed via the 6-Minute Walk Test (6MWT) and Timed 25-Foot Walk
(T25FW) during Visit 4 in addition to knee extensor maximal voluntary isometric strength. Both the
Modified Fatigue Impact Scale (MFIS) and Rochester Fatigue Diaries (RFD) were assessed prior to
each testing session to ensure consistent levels of fatigue across sessions [16,17]. Testing sessions were
rescheduled to a later date if an MFIS score greater than 2.5 standard deviations from previous scores
was recorded, or if upon the visual inspection of RFDs, elevated fatigue levels were present [16,17].
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Participants: The current sample consisted of 14 participants, including: 8 persons with MS
(3 females and 5 males), and 6 healthy persons without MS (3 females and 3 males) matched by
age, height, weight, and gender. Persons with MS were required to have a confirmed diagnosis of
relapsing–remitting MS from a physician, an Expanded Disability Status Scale (EDSS) score of ≤6.0
(minimal to moderate disability—may need intermittent or unilateral aid to walk 100 m), and be free
from a relapse for the 3 months prior to testing. A relapse was defined as a period of worsening
symptoms lasting longer than 24 h. Participants with any previous or current lower limb orthopedic
alignments or procedures (arthritis, hip replacement, knee surgery, etc.) were excluded. Participants
using prednisone or who had a steroid dose less than three months prior to testing were excluded.
Body Composition: Lower-limb composition was assessed using a whole-body Lunar dual-energy
X-ray absorptiometry scanner (with software version 13.60.033, GE-Lunar Prodigy Advanced, Madison,
WI, USA). Pre-scan calibration quality assurance indicated a low coefficient of variation (<0.2%).
Subjects were positioned in the center of the dual-energy X-ray absorptiometry table in the supine
position using standardized positioning; the arms were close to the sides of the body, and the legs
were secured by Velcro straps to ensure proper positioning and spacing between limbs for segmental
analysis. Subjects too wide for the scanning bed had each side of the body tested separately, and the
composition of both sides of the body were added together to estimate body composition. Assessment
of the lower limbs was used to determine any significant differences in the lean mass of the legs
between groups. From the full-body scans, separate regions of interest were made of the lower legs,
using the tibiofemoral joint of the knee and subtalar joint of the ankle as landmarks. The region of
interest for each lower limb was quality checked by two separate researchers to ensure accuracy.
Incremental Cycling Test: A magnetically braked cycle ergometer (Sport Excalibur, Lode;
B.V. Medical Technology, Groningen, The Netherlands) along with a metabolic cart (True One 2400,
Parvo Medics, Sandy, UT, USA) was utilized to perform all incremental cycling tests (ICTs). Subjects
were instructed to abstain from exercise and caffeine 12 h prior to testing and to fast three to four hours
prior to testing. Subjects were instructed to pedal at a cadence that was comfortable and they felt could
be maintained for an extended period of time. Following a one-minute rest period and a five-minute
warm up at 50 watts (W), the graded exercise test was initiated at a workload of 1.0 W per kilogram of
body mass (W × BWkg−1) and increased by 0.5 W × BWkg−1 every three minutes until the participant
reached task failure, as indicated by a pedal rate dropping more than 10 revolutions per minute from
their self-selected cadence [18]. Heart rate (HR) was measured via a telemetric HR monitor (Polar T31,
Polar Electro Inc., Bethpage, NY, USA) throughout the graded exercise test, and rating of perceived
exertion (RPE) was measured at the end of each three-minute stage [19]. Metabolic and ventilatory
data were continuously measured and averaged over 30-s intervals. VO2peak was indicated by the
highest 30-s average recorded during the final stage of the test.
Verification: VO2peak was verified using the protocol developed by Nolan et al. [20]. Participants
were given 20 min of rest between the completion of the ICT and before beginning the verification
protocol. Using the PPO obtained during the ICT, participants performed a multistage warm-up that
consisted of 2 min at 50% of PPO followed by 1 min at 70% of PPO. Then, the workload increased to 105%
of PPO, and participants were instructed to maintain their self-selected cadence for as long as possible.
When cadence decreased by greater than 10 revolutions per minute, exercise was terminated [20].
VO2peak was determined as the highest 30-s average obtained from either the initial ICT or the
verification protocol.
Submaximal ICT: Using the PPO and VO2peak collected from the ICT and verification protocol,
the subsequent submaximal ICT was designed in a manner that allowed for participants to exercise at
specific relative exercise intensities. The testing consisted of a 3-min warm-up at 25% of PPO followed
by 3-min stages at 50%, 60%, and 70% of the individual’s PPO. Metabolic and ventilatory data were
continuously measured and averaged over 30-s intervals. HR was measured throughout each test,
with RPE measured at the end of each stage. [19]. Power (measured in W) and force (indicated by peak
torque (N·m)) from each limb was collected during each stage to assess the presence of asymmetries.
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Additionally, mechanical efficiency was assessed during each stage and defined as the percent of
power produced during the crank arm cycle that translates to forces generating forward propulsion,
with higher values being indicative of greater efficiency.
Lower Limb Strength: Maximal voluntary isometric contractions (MVCs) of the knee extensors
were assessed using a dynamometer (KinCom model: KC125AP, Isokinetic International, East Ridge,
TN, USA). Subjects were seated with hip and knee angle set at 70◦. Participants were asked to perform
a series of warm-up isometric contractions at submaximal intensities with 2 to 3 min of rest between
contractions. Following the warm-up, participants performed 3 MVCs lasting 3 s each, with 3 min of
rest between contractions. Both legs were assessed, and the order was randomly selected. The two
highest values for each participant were averaged.
Walking Capacity: Both the T25FW and 6MWT are assessment tools utilized by both researchers
and clinicians to evaluate disease progression and walking capacity in PwMS [21,22]. The T25FW
requires participants to begin in a standing position and walk 25 feet as quickly as possible, but safely [21].
The participants were instructed to walk back to the starting point, and the test was performed again.
The dependent variable was the average amount of time (seconds) required to walk 25 feet over the
two trials [21]. The 6MWT was conducted on a 60-m marked course, and participants were instructed
to cover as much ground as possible in 6 min while walking [22]. The total distance covered was
recorded to the nearest meter [22].
Asymmetry Scores: Scores were assigned to strength measurements collected during the MVCs.
The equation below was used, with 0% indicating an even distribution of strength across the limbs,
and 100% indicating maximal asymmetry [3].




Power o f Weaker Limb
Power o f Stronger Limb
)]
100
The assignment of a stronger and weaker limb, in terms of power or torque production, was not
possible during the submaximal ICT. This was due to the lack of a consistent pattern of dominance in one
leg for force application and power production throughout the submaximal ICT. Limb preference has
been noted to change during bilateral movements depending on the complexity and conditions during
the movement [13,23]. For this reason, asymmetry values during the submaximal graded exercise
test were calculated as the absolute difference between the limbs (|left leg − right leg|), with higher
values indicating greater differences between limbs. Additionally, the percent difference between
contralateral limbs in muscle function has been previously used to detect asymmetry, with a threshold
of ≥10% being used to indicate asymmetry being present [14,24,25]. This method was used in addition
to statistical analysis to detect asymmetry.
Statistical Analysis: All analyses were performed using IBM SPSS Statistics (version 25.0; IBM
Corp., Armonk, NY, USA). Descriptive statistics were used to summarize the demographic data.
A t-test analysis of independent samples using difference scores was used to assess differences in
lower limb body composition between groups. T-tests on independent samples were used to assess
isometric strength asymmetry and walking capacity during functional performance tests between
groups. Two-way repeated measures analysis of variance (ANOVA) were used to detect group ×
intensity interactions for the power, force, and physiological variables collected during the submaximal
ICTs. When significant interactions and effects were found, Bonferroni corrections were performed for
post hoc analysis. An alpha level of ≤0.05 was the criteria to establish statistically significant differences.
Cohen’s d effect sizes were analyzed when appropriate, with values of 0.2, 0.5, and 0.8 indicating small,
moderate, and large effects, respectively [26]. Effect sizes for ANOVA were analyzed when appropriate
using eta-squared (η2). A value of 0.02 was considered a small effect, 0.13 was considered a medium
effect, and 0.26 was considered a large effect [26,27]. Bivariate Spearman correlations were used to
examine potential associations between asymmetries and walking performance. Correlation coefficient
values of 0.1, 0.3, and 0.5 were interpreted as small, moderate, and large, respectively [26].
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3. Results
Participant Characteristics: Fourteen individuals completed the study and were included in data
analysis. Five males and 3 females (n = 8) were included in the PwMS group, and 3 males and 3 females
(n = 6) were included in the Non-MS group. Descriptive and anthropometric data for both groups are
listed in Table 1. There were no significant between-group differences (p > 0.05) for all descriptive
and anthropometric variables. All the PwMS possessed a physician’s diagnosis of relapse remitting
MS, and had an average EDSS score of 1.87 ± 1.09 indicating a minimal impairment in a neurological
category. One visit for one subject was rescheduled to a later date due to elevated levels of fatigue as
assessed via the RFD and MFIS prior to the testing session.
Table 1. Participant characteristics.
Variable PwMS (n = 8) Non-MS (n = 6) p d
Age (yrs) 45.0 ± 12.1 45.5 ± 9.0 0.93 0.05
Height (cm) 174.0 ± 4.5 174 ± 10.4 0.93 0.00
Body Mass (kg) 94.5 ± 17.7 80.0 ± 6.2 0.79 1.09
Body Mass Index (kg/m2) 30.7 ± 6.2 26.6 ± 4.0 0.18 0.79
Body Fat (%) 41.1 ± 7.0 32.8 ± 14.2 0.17 0.74
Lean Mass (kg) 51.6 ± 6.6 51.8 ± 9.4 0.95 0.02
Fat Mass (kg) 37.0 ± 11.9 25.7 ± 11.9 0.10 0.95
Physical Activity (min/wk) 206.0 ± 180.0 260.0 ± 129.0 0.55 0.34
EDSS 1.9 ± 1.1 N/A N/A
Data are mean ± SD. Cohen’s d = effects sizes, EDSS = expanded disability status scale, PwMS = persons with
multiple sclerosis.
Body Composition: Using the lower limb classifications (i.e., strong and weak) to determine
strength asymmetry scores, the differences (strong–weak) in lean and fat mass for lower limbs are
presented for each group in Table 2. The results of the independent t-test indicated no significant
differences between groups (p > 0.05) for between-limb differences in the lean mass, fat mass, and fat
percentage of the lower limbs with small, small, and large effect sizes observed, respectively.
Table 2. Difference between lower limbs for lean and fat mass.
Variable PwMS ∆ Non-MS ∆ p d
Lean Mass (kg) 0.15 ± 0.21 0.22 ± 0.15 0.48 0.38
Fat Mass (kg) 0.08 ± 0.11 0.13 ± 0.13 0.49 0.41
Lower-Limb Fat (%) 0.00 ± 0.00 0.02 ± 0.04 0.26 0.71
Data are mean ± SD. Cohen’s d = effect sizes.
Initial ICT: Physiological variables collected during the initial ICT are reported in Table 3.
No significant differences (p > 0.05) between groups were observed, with small effect sizes for
all variables.
Table 3. Physiological variables during the initial incremental cycling test.
Variable PwMS Non-MS p d
VO2peak (mL/kg/min) 24.0 ± 7.8 28.0 ± 10.8 0.43 0.42
Max Heart Rate (bpm) 157.2 ± 23.1 158.1 ± 25.5 0.95 0.04
Peak Power Output (W) 148.0 ± 39.5 168.0 ± 70.0 0.52 0.35
Data are mean ± SD. Cohen’s d = effect sizes, VO2peak = peak oxygen consumption.
Submaximal ICT Variables: During submaximal ICTs, both the power and force for each leg
were assessed in addition to efficiency. The results are reported in Table 4 for both absolute and
percent differences in power and force between limbs and efficiency during each stage. No statistically
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significant group × intensity interactions or main effects were present when examining the absolute
and percent differences in power and force. However, a main effect was present for intensity when
examining efficiency (F = 99.2, p = 0.00, η2 = 0.948). Post hoc analysis indicated that when collapsed
across groups, efficiency significantly increased as intensity increased. Figure 1 illustrates the average
percent difference in power and force for both groups across each stage. A large range of values were
observed for both power (range at 50%: 0.70 to 43.9; 60%: 0.10 to 37.3; 70%: 0.58 to 32.4) and force
(range at 50%: 0.09 to 38.9; 60%: 2.69 to 26.5; 70%: 0.95 to 25.2) in PwMS, while a smaller range of
values was observed in the Non-MS group for power (range at 50%: 0.38 to 13.1; 60%: 1.78 to 10.8; 70%:
0.12 to 10.7) and force (range at 50%: 0.31 to 18.2; 60%: 3.12 to 14.5; 70%: 1.53 to 13.9).
Table 4. Variables from the submaximal incremental cycling test.
Variable Group 50% PPO 60% PPO 70% PPO
Abs. Diff Power (W)
PwMS 12.7 ± 11.2 11.4 ± 9.9 12.2 ± 8.6
Non-MS 4.88 ± 5.3 5.5 ± 4.7 3.5 ± 3.7
d 0.89 0.76 1.3
% Diff Power (%)
PwMS 20.1 ± 18.6 15.5 ± 14.8 13.9 ± 12.1
Non-MS 6.1 ± 5.4 5.4 ± 3.7 3.4 ± 4.0
d 1.02 0.93 1.16
Abs. Diff Force (N·m)
MS 7.8 ± 6.9 5.7 ± 3.7 5.9 ± 5.2
Non-MS 3.2 ± 3.4 4.0 ± 2.1 3.8 ± 1.7
d 0.83 0.56 0.52
% Diff Force (%)
PwMS 16.4 ± 13.3 12.0 ± 7.8 10.4 ± 8.1
Non-MS 7.1 ± 6.5 8.7 ± 4.6 8.0 ± 4.3
d 0.88 0.51 0.36
Efficiency (%)
PwMS 56.4 ± 11.3 61.8 ± 12.7 67.2 ± 13.7
Non-MS 62.6 ± 13.2 67.9 ± 12.2 74.5 ± 11.6
d 0.50 0.49 0.58
Data are mean ± SD. Cohen’s d = effects sizes. Abs. Diff = absolute difference between lower limbs, % Diff = percent
difference between lower limbs, PPO = peak power output.
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Figure 1. Average lower limb asymmetry in power and force. Data are presented as mean ± standard
error. Dotted line indicates 10% threshold for asymmetry.
Walking Capacity and MVCs: Individual results and group averages for performance on the
T25FW test and 6MWT are displayed in Figure 2. Figure 3 represents individual results and the group
average for knee extensor strength asymmetry scores. No statistically significant differences between
groups were detected for performance on the T25FW, 6MWT, and knee extensor strength asymmetry
scores (p > 0.05).
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Correlation analysis: Correlation analysis was performed to determine the association between
variables collected during the submaximal ICTs and walking performance (T25FW and 6MWT) (Table 5).
No significant correlations between physiological variables and walking capacity tests were present
in PwMS (p > 0.05). However, the Non-MS group did display a significant correlation between
performance on the T25FW and efficiency at 50% (p = 0.05, r = −0.812), 60% (p = 0.04, r = −0.833),
and 70% (p = 0.24, r = −0.870) PPO, as well as a percent difference in force at 70% PPO (p = 0.03,
r = 0.844). Additionally, no significant associations were present between knee extensor strength
asymmetry scores and performance on T25FW and 6MWT (p > 0.05) (Table 6).
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Table 6. Correlations coefficients between walking performance and knee extensor strength asymmetry
scores.




Pearson’s product moment correlation coefficient reported. T25FW = Timed 25-foot Walk; 6MWT = 6-Min Walk
Test; KE = knee extensor.
4. Discussion
The current study examined the effects of exercise intensity on the physical manifestation of lower
limb asymmetry when exercising in a bipedal movement in PwMS. We hypothesized that PwMS would
exhibit greater levels of asymmetry in power and force production compared to Non-MS participants.
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However, our results indicate that no statistically significant differences were present between the
groups for levels of asymmetry in force application power and production; thus, we rejected our
hypothesis. Additionally, we hypothesized that exercise intensity would have a significant effect
on the level of asymmetry in power and force production in PwMS, with higher exercise intensities
eliciting greater levels of asymmetry. Our results show that exercise intensity did not have a significant
effect on levels of asymmetry in PwMS; thus, we rejected our hypothesis. It was revealed that a main
effect was present for exercise intensity on efficiency, indicating greater levels of efficiency at higher
exercise intensities.
Statistically significant lower limb asymmetry in PwMS has been reported previously for VO2peak,
PPO, and work performed during unilateral cycling [11–13]. However, the current study did not
observe statistically significant levels of asymmetry in PwMS. The contrasting findings between
the current study and that of the previous literature could potentially be due to methodological
differences in the assessment of asymmetry. Previous investigations have been limited to assessing
each limb individually during unilateral cycling, while the current study was able to assess both limbs
simultaneously during bipedal cycling [11–13]. Compared to traditional bipedal cycling, unilateral
cycling may potentially require the activation of different muscles, or greater activation of the same
muscles at different points throughout the crank arm cycle resulting in a distinct metabolic response.
Additionally, the exercise intensity in which lower limb asymmetry was assessed differed between the
current study and previous literature. Previously, asymmetry in power production during cycling
has only been assessed at intensities equal to PPO and 20% of PPO during unilateral cycling, while
the current study assessed asymmetry at 50%, 60%, and 70% of PPO during bipedal cycling [11–13].
Previous investigations have observed an inverse association between exercise intensity and power
production asymmetry in trained cyclists [28–30]. Although the current data suggest that exercise
intensity does not impact asymmetry levels in persons with MS, its role cannot be completely ruled
out currently. Finally, the MS cohort in the current study had an average EDSS of 1.87 ± 1.09 (minimal
impairment), indicating a lower disability level compared to the participants of previous investigations
who had an average EDSS of 2.6 ± 1.6 (mild to moderate impairment) [12,13]. It can be speculated that
asymmetry may not become prominent until higher levels of disability are reached.
Previous investigations examining asymmetries in muscle function have utilized percent
differences between contralateral limbs in outcome measures to evaluate the presence of asymmetry.
A percent difference between contralateral limbs in muscle function that is ≥10% has been previously
defined to indicate the presence of asymmetry [14,24,25]. Although a statistically significant difference
in asymmetry between groups was not present in the current study, the group average for the PwMS
group exhibited asymmetry values ≥10% for power and force at 50%, 60%, and 70% of PPO (Figure 1).
The group average for the Non-MS group did not exhibit asymmetry levels that exceeded 10% for
either power or force at any of the measured exercise intensities. Additionally, PwMS had a higher
percentage of the sample that reached the ≥10% threshold for both variables at all three exercise
intensities compared to the Non-MS group (Figure 4). The levels of asymmetry in power and force
production observed in the current study are similar to those previously reported for power production
during unilateral cycling in PwMS (10–28%) [11]. It has been argued previously that statistical analysis
in nonhomogeneous clinical populations may mask clinically relevant differences, and an alternative
analysis may provide additional insight [31]. Assessing asymmetry based on a defined threshold may
provide better insight than traditional analysis when observing persons with MS. Future research
is needed to determine a clinically meaningful level of asymmetry in order to provide guidance for
future analysis.
Both group averages for MVC strength exceeded the 10% threshold for asymmetry, with a greater
portion of the Non-MS group exceeding the threshold than the PwMS group (Figure 3). The reason for
this is unclear, but it could be speculated that greater between-limb differences in the body composition
of the lower limbs could play a role. The Non-MS group had greater between-limb differences in fat
mass, lean mass, and fat % for the lower limbs compared to the PwMS with small to large effective
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sizes observed, although these differences were not statistically different from the PwMS. The ability
of muscles to generate force is related to measures of muscle cross-sectional area and volume [32].
The between-limb differences in body composition measures may have contributed to the high levels
and prevalence of asymmetry seen in the Non-MS group.
Efficiency in pedaling during cycling involves the application of forces to the pedals in a manner
that allows for the greatest translation of power into forward propulsion [33]. Due to limitations
in equipment, the current study was only able to calculate efficiency in a manner that took into
account the application of forces and translation into propulsive power of both pedals in combination
with each other. However, this manner of application still has the potential to indicate imbalances
in performance between the lower limbs. Higher levels of asymmetry in force production during
cycling have been observed to induce lower levels of pedaling efficiency [33,34]. The current study did
not observe any significant group × intensity interactions for pedaling efficiency, but a main effect
for exercise intensity was present with levels of efficiency increasing as exercise intensity increased.
This phenomenon has been observed in previous research with cyclists, and has been speculated to
be related to improved muscular recruitment strategies resulting in improved force application and
the minimization of the development of fatigue [33,35]. The improvement in efficiency in the current
study is an interesting finding, as it has been documented that PwMS can experience a transient
worsening of disease symptoms, as indicated by impairment in central motor conduction time and
cortical excitability related to increases in core temperature during vigorous physical exertion [36–38].
The increase in core temperature impairs central motor conduction time and cortical excitability as a
result of slowed or blocked conduction in demyelinated lesions in the central nervous system [38].
The observed improvement in efficiency with increasing exercise intensity in the current study may
be due to the lower disability status within the current sample. The previously mentioned transient
worsening symptoms may not have reached a degree that impaired the participants’ performance.
Correlation analysis was run between the percent asymmetry in power, force, and efficiency at
each recorded exercise intensity and walking capacity. Interestingly, no significant correlations were
present between cycling variables and performance on walking tasks when groups were combined
or when analyzed with PwMS alone. Previous investigations examining the impact of asymmetry
on walking performance in persons with MS have reported mixed results [13,14,39]. Larson et al.
and Sandroff et al. both found that higher levels of asymmetry in PPO and knee extensor strength,
respectively, were associated with lower performance walking performance [13,39]. However, Proessl
et al. did not detect a significant association between knee extensor strength asymmetry and walking
capacity in PwMS [14]. The results of the current study are in agreement with the results reported by
Proessl et al. in that measures of asymmetry did not significantly relate to walking performance [14].
This is an interesting finding, as the levels of asymmetry in the current study are similar to those
previously reported. Perhaps asymmetry does not play a significant role in walking performance until
higher levels of disability are reached, as indicated by reductions in ambulation. Future research is
needed to examine the association between measurements of asymmetry in various variables associated
with lower extremity performance across a wide spectrum of ambulation capabilities to establish
any associations.
We must acknowledge that our study is not without limitations. First, the current sample
size is small, and the distribution of males and females is not representative of the MS population.
Additionally, during the submaximal ICTs, the progressive nature of the workload may have allowed
for development fatigue in a manner that may have influenced the asymmetry measures. Future
studies investigating asymmetry should consider testing in a manner that reduces the accumulation of
fatigue. Additionally, only assessing the strength asymmetry of the knee extensors may have inhibited
the ability to determine the impact of asymmetry on walking capacity, as knee flexor strength has
been shown to be a greater contributor to walking capacity in persons with MS [40]. Despite these
limitations, the current authors feel that the findings of this study provide valuable insight to the area
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of asymmetries in muscle function in PwMS by being the first study to assess asymmetry in a natural
bipedal movement.
5. Conclusions
In conclusion, the current study is the first study that allows for researchers to observe and analyze
asymmetry between the lower limbs during a bipedal movement during submaximal exercise, rather
than unilaterally and at maximal effort. The current study did not find any statistical difference in
levels of asymmetry between PwMS and Non-MS in regard to power and force at 50%, 60%, and 70% of
PPO during cycling and for knee extensor strength. Additionally, no statistically significant differences
in efficiency during cycling, walking performance, and the MVC strength asymmetry score of the
knee extensors were detected between groups. Also, measures of asymmetry and efficiency did not
exhibit a significant association with walking performance in PwMS. Although the percent difference
for asymmetry in power and force were not statistically different, the group average for PwMS
displayed asymmetry levels above the established 10% threshold, indicating significant asymmetry
for cycling variables, while the Non-MS group did not. Additionally, a greater portion of the PwMS
sample exceeded the 10% threshold for asymmetry for power and force asymmetry than the Non-MS
group. However, a greater portion of the Non-MS group exceed the 10% threshold for MVC strength
asymmetry. This may be explained by greater between-limb differences in the body composition
measures of the lower limbs. The current authors feel that these results provide additional support for
the use of clinically meaningful differences when assessing asymmetry in this population, rather than
relying solely on traditional statistical analyses. Future research is needed to establish a meaningful
threshold for asymmetry specific to persons with MS. The current authors also speculate that, based on
the findings of the current study and previous investigations, the impact of asymmetry may be
dependent on ambulation capacity, and future research is needed to establish this association.
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